William E. Rote - Net Worth and Insider Trading
William E. Rote Net Worth
The estimated net worth of William E. Rote is at least $1 Million dollars as of 2024-11-05. William E. Rote is the SENIOR VICE PRESIDENT, R&D of Travere Therapeutics Inc and owns about 84,455 shares of Travere Therapeutics Inc (TVTX) stock worth over $1 Million. Details can be seen in William E. Rote's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William E. Rote has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William E. Rote
William E. Rote Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William E. Rote owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .
Click here to see the complete history of William E. Rote’s form 4 insider trades.
Insider Ownership Summary of William E. Rote
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-09-09 | Senior Vice President & R&D |
William E. Rote Latest Holdings Summary
William E. Rote currently owns a total of 1 stock. William E. Rote owns 84,455 shares of Travere Therapeutics Inc (TVTX) as of September 9, 2024, with a value of $1 Million.
Latest Holdings of William E. Rote
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-09-09 | 84,455 | 17.75 | 1,499,076 |
Holding Weightings of William E. Rote
William E. Rote Form 4 Trading Tracker
According to the SEC Form 4 filings, William E. Rote has made a total of 23 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 23 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 4,387 shares on September 9, 2024, which brought William E. Rote around $50,538.
Insider Trading History of William E. Rote
- 1
William E. Rote Trading Performance
William E. Rote Ownership Network
Ownership Network List of William E. Rote
Ownership Network Relation of William E. Rote
William E. Rote Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
William E. Rote is the Senior Vice President & R&D of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Medical Officer Jula Inrig , director & Chief Executive Officer Eric M Dube , and Chief Financial Officer Christopher R. Cline .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, William E. Rote made 4 insider transaction in Travere Therapeutics Inc (TVTX) with a net sale of 9,089. Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,823 shares made by Christopher R. Cline , a net sale of 9,089 shares made by Elizabeth E Reed , and a net sale of 33,453 shares made by Eric M Dube .
In summary, during the past 3 months, insiders sold 117,969 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 117,969 shares. During the past 18 months, 150,147 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 150,147 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
William E. Rote Mailing Address
Above is the net worth, insider trading, and ownership report for William E. Rote. You might contact William E. Rote via mailing address: C/o Retrophin, Inc., 3721 Valley Centre Drive, Suite 200, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
